China NMPA Drug Inspection - Bozhou Yonggang Pharmaceutical Factory Co., Ltd. - ground beetle

The Liaoning Provincial Food and Drug Administration announced on December 4, 2017, the results of re-inspections for two batches of drugs previously deemed substandard. Operating under the broader regulatory framework of the National Medical Products Administration, the provincial body ensures pharmaceutical quality and safety. The re-inspection was conducted by the Liaoning Provincial Institute for Drug Inspection and Testing to verify compliance after initial quality concerns. The first re-inspection involved Glauber's salt (batch number 600002291), manufactured by Beijing Tongrentang (Bozhou) Pharmaceutical Pieces Co., Ltd., with the sample originating from Dandong Kangda Traditional Chinese Medicine Clinic. The second concerned ground beetle (batch number 170502), produced by Bozhou Yonggang Pharmaceutical Pieces Factory Co., Ltd., sourced from Liaoning Tasly Pharmaceutical Logistics Co., Ltd. Both batches, previously identified with quality issues, successfully passed their re-inspection, indicating that the initial concerns have been addressed and the products now meet required regulatory standards. This announcement confirms the resolution of these quality control matters.